Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells

Blood

Volumn 98, Issue 3, 2001, Pages 736-742

  Lehner, Manfred ^a   Felzmann, Thomas ^a   Clodi, Katharina ^a   Holter, Wolfgang ^a,b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; S6 KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035437194     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.3.736     Document Type: Article

References (46)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
2. Diefenbach A, Schindler H, Donhauser N, et al. Type I interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 1998;8:77-87.
3. Helfgott DC, May LT, Sthoeger Z, Tamm I, Sehgal PB. Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts. J Exp Med. 1987;166:1300-1309.
4. Hayes MP, Enterline JC, Gerrard TL, Zoon KC. Regulation of interferon production by human monocytes: requirements for priming for lipopolysaccharide-induced production. J Leukoc Biol. 1991;50:176-181.
5. Zachoval R, Abb J, Zachoval V, Deinhardt F. Circulating interferon in patients with acute hepatitis A. J Infect Dis. 1986;153:1174-1175.
6. Zachoval R, Abb J, Zachoval V, et al. Interferon alpha in hepatitis type B and non-A, non-B. Defective production by peripheral blood mononuclear cells in chronic infection and development of serum interferon in acute disease. J Hepatol. 1988;6:364-368.
7. von Sydow M, Sonnerborg A, Gaines H, Strannegard O. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses. 1991;7:375-380.
8. Feldman SB, Ferraro M, Zheng HM, et al. Viral induction of low frequency interferon-alpha producing cells. Virology. 1994;204:1-7.
9. Ferbas JJ, Toso JF, Logar AJ, Navratil JS, Rinaldo CRJ. CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol. 1994;152:4649-4662.
10. Cella M, Salio M, Sakakibara Y, et al. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med. 1999;189:821-829.
11. Karp CL, Biron CA, Irani DN. Interferon beta in multiple sclerosis: is IL-12 suppression the key? Immunol Today. 2000;21:24-28.
12. McRae BL, Semnani RT, Hayes MP, van Seventer GA. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol. 1998;160:4298-4304.
13. Cousens LP, Orange JS, Su HC, Biron CA. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci U S A. 1997;94:634-639.
14. Chehimi J, Starr SE, Frank I, et al. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med. 1994;179:1361-1366.
15. Lewerenz M, Mogensen KE, Uze G. Shared receptor components but distinct complexes for alpha and beta interferons. J Mol Biol. 1998;282:585-599.
16. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284:1835-1837.
17. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5:919-923.
18. Sehgal PB, Sagar AD. Heterogeneity of poly(I) x poly(C)-induced human fibroblast interferon mRNAspecies. Nature. 1980;288:95-97.
19. Gribaudo G, Ravaglia S, Caliendo A, et al. Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology. 1993;197:303-311.
20. Yeow WS, Lawson CM, Beilharz MW. Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. J Immunol. 1998;160:2932-2939.
21. Maitra RK, Silverman RH. Regulation of human immunodeficiency virus replication by 2′,5′-oligoadenylate-dependent RNase L. J Virol. 1998;72:1146-1152.
22. McRae BL, Nagai T, Semnani RT, van Seventer JM, van Seventer GA. Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood. 2000;96:210-217.
23. Noraz N, Lathey JL, Spector SA. Human cytomegalovirus-associated immunosuppression is mediated through interferon-alpha. Blood. 1997;89:2443-2452.
24. Karp CL, Wysocka M, Ma X, et al. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol. 1998;28:3128-3136.
25. Rieser C, Papesh C, Herold M, et al. Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2. Blood. 1998;91:3112-3117.
26. Docke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFNgamma treatment. Nat Med. 1997;3:678-681.
27. Rieser C, Ramoner R, Bock G, et al. Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: enhancement of c-fms expression by interleukin-10. Eur J Immunol. 1998;28:2283-2288.
28. de Waal M, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209-1220.
29. Adler B, Adler H, Jungi TW, Peterhans E. Interferon-alpha primes macrophages for lipopolysaccharide-induced apoptosis. Biochem Biophys Res Commun. 1995;215:921-927.
30. Lopez-Collazo E, Hortelano S, Bosca L. Interferon-alpha/beta inhibits the apoptosis induced by lipopolysaccharide and interferon-gamma in murine peritoneal macrophages. J Interferon Cytokine Res. 1998;18:461-467.
31. Santini SM, Lapenta C, Logozzi M, et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med. 2000;191:1777-1788.
32. Paquette RL, Hsu NC, Kiertscher SM, et al. Interferon-alpha and granulocyte-macrophage colonystimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leukoc Biol. 1998;64:358-367.
33. Aman MJ, Tretter T, Eisenbeis I, et al. Interferonalpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood. 1996;87:4731-4736.
34. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988;141:2407-2412.
35. Lu L, Bonham CA, Chambers FG, et al. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol. 1996;157:3577-3586.
36. Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol. 1994;55:682-684.
37. Zhang X, Laubach VE, Alley EW, et al. Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma. J Leukoc Biol. 1996;59:575-585.
38. Sharara AI, Perkins DJ, Misukonis MA, et al. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med. 1997;186:1495-1502.
39. Weinberg JB, Misukonis MA, Shami PJ, et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood. 1995;86:1184-1195.
40. Willems F, Amraoui Z, Vanderheyde N, et al. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood. 2000;95:3478-3482.
41. Servet-Delprat C, Vidalain PO, Azocar O, et al. Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. J Virol. 2000;74:4387-4393.
42. Koppi TA,Tough-Bement T, Lewinsohn DM, Lynch DH, Alderson MR. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells. Eur J Immunol. 1997;27:3161-3165.
43. Williams MA, Withington S, Newland AC, Kelsey SM. Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo. J Infect Dis. 1998;178:1421-1433.
44. Hayes MP, Zoon KC. Priming of human monocytes for enhanced lipopolysaccharide responses: expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor. Infect Immun. 1993;61:3222-3227.
45. Corssmit EP, Heijligenberg R, Hack CE, et al. Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol. 1997;107:359-363.
46. Felzmann T, Buchberger M, Lehner M, et al. Functional maturation of dendritic cells by exposure to CD40L transgenic tumor cells, fibroblasts or keratinocytes. Cancer Lett. In press.